North America Pharmaceutical Isolator Market Size and Competitive Analysis by 2028
Historic Data: 2019-2020 | Base Year: 2021 | Forecast Period: 2022-2028North America Pharmaceutical Isolator Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Open Isolator and Closed Isolator), Pressure (Positive Pressure and Negative Pressure), Configuration (Floor Standing, Modular, Mobile, and Compact), Application (Aseptic Isolators, Containment Isolators, Sampling and Weighing Isolators, Fluid Dispensing Isolators, and Others), and End User (Hospitals, Pharmaceutical and Biotechnology Companies, Research and Academic Laboratories, and Others)
- Report Date : Nov 2021
- Report Code : TIPRE00025888
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 137
The North America pharmaceutical isolator market is expected to grow from US$ 2,532.56 million in 2021 to US$ 4,409.02 million by 2028; it is estimated to grow at a CAGR of 8.2% from 2021 to 2028.
The US, Canada, and Mexico are economies in North America. Growing investments by pharmaceutical and biotechnology industry is expected to surge the market growth. Several big and small pharmaceutical companies are engaged in the development and manufacturing of new and novel molecules for life-threatening conditions. Pharmaceutical isolator systems have been regarded as a key technology in the drug discovery process. Thus, the adoption of pharmaceutical isolators is increasing to ensure contamination-free manufacturing and product handling. The pharmaceutical isolator provides safety to an operator from the exposure of harmful drugs, eliminates the possibilities of cross-contamination, and maintains the standard of drug quality. In the pharmaceutical industry, it is extremely important to maintain immense caution during the product manufacturing process. Different types of isolators are available in the pharmaceutical market that provide an optimum level of sterility in the product manufacturing process. The handling of pharmaceuticals with high potency ingredients, such as hormones and antibiotics. Biologic drugs need a greater level of precautions. Increased investments by pharmaceutical and biotechnology companies and extensive drug pipelines for the treatment of various chronic diseases, such as cancer, cardiovascular disorders, metabolic disorders, immunological disorders, and neurological disorders, are the prominent drivers for the growth of the North America pharmaceutical isolator market.
In case of COVID-19, North America is highly affected specially the US. the pandemic has brought several growth opportunities to the pharmaceutical and biopharmaceutical companies to strengthen their research and development for innovating vaccine against the coronavirus. In May 2020, The U.S. Department of Health and Human Services had collaborated with private players to expand pharmaceutical products in the United States against COVID-19 and further medical emergencies. Phlow Corporation of Richmond, Virginia, leads the collaboration. It has the capacity to produce active pharmaceutical ingredients (APIs) and chemical compounds for critical medicines. It is expected that the production of pharmaceutical products will assist in preventing drug shortages, especially during the COVID-19 pandemic. The collaboration aims to provide the health care systems with complete, sterile, and injectable generic medicines at risk of shortage. The agreement between the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at HHS, is done for four years with US$ 354 million. Thus, the collaboration is expected to show a positive impact on the pharmaceutical isolator market in the coming few years.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America pharmaceutical isolator market. The North America pharmaceutical isolator market is expected to grow at a good CAGR during the forecast period.
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
North America Pharmaceutical Isolator Market Segmentation
North America Pharmaceutical Isolator Market – By Type
- Open Isolators
- Closed Isolators
North America Pharmaceutical Isolator Market – By Pressure
- Positive Pressure
- Negative Pressure
North America Pharmaceutical Isolator Market – By Configuration
- Floor Standing
- Modular
- Compact
- Mobile
North America Pharmaceutical Isolator Market – By Application
- Aseptic
- Sampling & Weighing
- Fluid Dispensing
- Containment
- Others
North America Pharmaceutical Isolator Market – By End User
- Pharmaceutical and Biotechnology Companies
- Hospitals
- Research and Academic Laboratories
- Other
North America Pharmaceutical Isolator Market, by Country
- US
- Canada
- Mexico
North America Pharmaceutical Isolator Market -Companies Mentioned
- Azbil Telstar
- Bioquell (Ecolab Solution)
- Comecer
- Fedegari Autoclavi S.p.A.
- Getinge AB
- Hosokawa Micron Group
- Nuaire Inc.
- Schematic Engineering Industries
North America Pharmaceutical Isolator Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 2,532.56 Million |
| Market Size by 2028 | US$ 4,409.02 Million |
| Global CAGR (2021 - 2028) | 8.2% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
Market Research & Consulting
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.
We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, Market Research
The research report delivered details on drivers and restraints, trends, and opportunities, along with strategic activities in the market. Previously, we were struggling to get reliable information.
Manager Medical Devices ManufacturingReason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.
- Azbil Telstar
- Bioquell (Ecolab Solution)
- Comecer
- Fedegari Autoclavi S.p.A.
- Getinge AB
- Hosokawa Micron Group
- Nuaire Inc.
- Schematic Engineering Industries
Get Free Sample For